Trade Summary

11 months ago, Pace Gary W, serving as Dir at Cardiff Oncology, Inc. (CRDF), purchased 290,000 shares at $2.45 per share, for a total transaction value of $710,500.00. Following this transaction, Pace Gary W now holds 2,676,352 shares of CRDF.

This purchase represents a 12.00% increase in Pace Gary W's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, July 30, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, July 31, 2025 at 12:05 PM ET, 1 day after the trade was made.

Cardiff Oncology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.